Post-doctoral position at the Institute of Genetics and Molecular and Cellular Biology (Illkirch, France) in the team of Daniel Metzger

Project : “Identification of new biomarkers and drug targets for prostate cancer

Prostate cancer (PCa) is the second most commonly diagnosed neoplasia in men worldwide and one of the major causes of cancer-related death in men. Advances made in the management of PCa have markedly improved survival rates in men with localized disease, but current treatments have considerable side effects. Moreover, no reliable biomarkers are available to predict relapses, and patients with metastatic disease have limited treatment options and an overall poor prognosis.
Our laboratory generated Pten(i)pe−/− mice, in which the tumor suppressor gene Pten is selectively ablated in luminal prostatic epithelial cells at adulthood. We have shown that these mice faithfully recapitulate disease progression in humans, and are valuable tools to provide insights in prostate tumorigenesis. Our recent results based on single cell transcriptomics and histological analyses revealed that the evolution of prostatic tumors is associated with luminal epithelial cell plasticity and immunosuppression.
The aim of the project is to characterize the underlying molecular mechanisms, identify new biomarkers of tumor evolution and new drug targets, using cutting-edge technics.

We offer a 2-year contract, starting October 2022, with the possibility of extension.

Requirements

Applicants should have a PhD in biological science, a strong background in cellular and molecular biology with a sound knowledge in cancer research and genetics. Expertise in bioinformatics will be a plus.

Your responsibilities will include:

  • Molecular biological assays on tissues of genetically modified mice
  • Organoid cultures
  • Single cell RNAseq and spatial single cell RNAseq analyses of mouse and human prostate tumors
  • Mentoring graduate and undergraduate trainees

Your application

Candidates should send a curriculum vitae with a publication list, a short summary of research achievements and mastered techniques, as well as contact information of at least two references to .

 

More information

 


Appels à projets

  • Inserm
    Date limite dépôt dossier : 26/02/2026

    AAP Cancers de mauvais pronostic MCMP

  • Cancéropôle Est
    Date limite dépôt dossier : 03/03/2026

    Soutien à l'émergence de projets - Innovation translationnelle

  • Cancéropôle Est
    Date limite dépôt dossier : 03/03/2026

    Soutien à l'émergence de projets - Sciences humaines et sociales, épidémiologie et santé publique

  • Cancéropôle Est
    Date limite dépôt dossier : 03/03/2026

    Soutien à l'émergence de projets transfrontaliers

  • GIRCI Est
    Date limite dépôt lettre d’intention : 03/03/2026

    ReSP-Ir Recherche en soins primaires

  • INCA
    Date limite dépôt dossier : 05/03/2026

    Appel à candidatures "Origines et causes des cancers pédiatriques"

  • Fondation ARC, SFC
    Date limite dépôt dossier : 10/03/2026

    Prix de mobilité internationale pour jeunes chercheurs cliniciens

  • INCA, IReSP
    Date limite dépôt dossier : 12/03/2026

    Conduites addictives et drogues

  • Fondation ARC
    Date limite dépôt dossier : 16/03/2026

    SIGN’IT 2026

  • Ligue contre le cancer
    Date limite dépôt dossier : 27/03/2026

    Subvention colloque

  • Ligue contre le cancer
    Date limite dépôt lettre d’intention : 16/04/2026

    Recherche-Action

  • INCA, IReSP
    Date limite dépôt dossier : 20/04/2026

    Subventions doctorales - Conduites addictives et drogues (CAD)

Agenda

5 mars 2026

Webinaire "La recherche en santé et en oncologie"

9 avril 2026
Date limite pour s’inscrire : 09/03/2026

Journée SHS inter-Cancéropôles “La place des sciences humaines et sociales en oncologie”

9-13 mars 2026

International Conference on H/D exchange Mass Spectrometry IC-HDX 2026